AMPH Amphastar Pharmaceuticals Inc.

15.66
-0.12  -1%
Previous Close 15.78
Open 15.84
Price To book 2.17
Market Cap 723428452
Shares 46,195,942
Volume 149,442
Short Ratio 13.26
Av. Daily Volume 189,408

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018952
  2. 8-K - Current report 171018182
  3. 8-K - Current report 17977517
  4. 8-K - Current report 17901378
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 17827809

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Albuterol DPI
Asthma
CRL announced February 21, 2017.
Naloxone Intranasal
Opioid overdose
CRL issued December 27, 2016.
Primatene Mist (epinephrine inhalation aerosol)
Asthma

Latest News

  1. ETFs with exposure to Amphastar Pharmaceuticals, Inc. : September 12, 2017
  2. Amphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017
  3. Featured Company News - Dr. Reddy's Labs Announces the Launch of Anti-Depressant and Muscle Relaxant Tablets in the US
  4. Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference
  5. Amphastar Pharmaceuticals, Inc. – Value Analysis (NASDAQ:AMPH) : August 15, 2017
  6. Edited Transcript of AMPH earnings conference call or presentation 9-Aug-17 9:00pm GMT
  7. Trump Declares Opioid Crisis National Emergency - These 6 Drug Makers Can Help
  8. Amphastar beats 2Q profit forecasts
  9. Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017
  10. Investor Network: Amphastar Pharmaceuticals, Inc. to Host Earnings Call
  11. Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017
  12. Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMPH-US : August 1, 2017
  13. Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.
  14. U.S. jury sides with Amphastar over Momenta in drug patent trial
  15. ​Jury nixes Momenta patent case that sought $938M in damages
  16. Cramer's lightning round: GameStop just can't seem to go ...
  17. Cramer's lightning round: GameStop just can't seem to go higher
  18. ETFs with exposure to Amphastar Pharmaceuticals, Inc. : July 13, 2017
  19. Amphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 8, 2017